siRNA treatment lowers triglycerides in individuals with uncommon problem

.RESEARCH HIGHLIGHT.19 September 2024.

Plozasiran lowered triglyceride amounts by 80% as well as lowered the threat of pancreatitis in people along with consistent chylomicronemia, with or without a genetic diagnosis.